(Q81013987)
Statements
Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose (English)
Joseph F Contrera
Edwin J Matthews
Naomi L Kruhlak
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference